Early Stress-Response Gene REDD1 Controls Oxazolone-Induced Allergic Contact Dermatitis.

Area of Science:

• Immunology
• Dermatology
• Metabolism

Background:

• REDD1 (regulated in development and DNA damage response 1) is an energy sensor and stress-induced mTOR inhibitor.
• Emerging evidence links REDD1 to inflammation and immune responses.
• Its specific role in T cell-mediated skin inflammation, like allergic contact dermatitis (ACD), requires further elucidation.

Purpose of the Study:

• To investigate the role of REDD1 in a murine model of oxazolone-induced allergic contact dermatitis (ACD).
• To assess the impact of REDD1 deficiency on T cell activation, immune cell infiltration, and inflammatory responses in the skin.

Main Methods:

• Utilized Redd1 knockout (KO) and wild-type (WT) mice in an oxazolone-induced ACD model.
• Compared immune indices including ear edema, cellular infiltration, inflammatory gene expression, and glucocorticoid response.
• Analyzed T cell populations, cytokine production, and immune cell infiltration in naive and challenged mouse ears.

Main Results:

• Redd1 KO mice exhibited impaired early T cell expansion and cytokine production post-sensitization.
• Naive Redd1 KO mice showed higher steady-state populations of T cells and other immune cells in the skin.
• Oxazolone challenge in Redd1 KO mice resulted in significantly reduced ear edema, immune cell infiltration, and inflammatory mediator induction (IFN-γ, IL-4, TSLP, IL-33, IL-1β, IL-6, TNF-α).

Conclusions:

• REDD1 is crucial for initiating ACD by driving naive T cell activation.
• REDD1 plays a significant role in the effector phase of ACD by promoting immune cell trafficking.
• REDD1 acts as an essential immune modulator in T cell-mediated skin inflammation.